Cargando…
Different Aspects of Emetine’s Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19
[Image: see text] In the global movement to find the appropriate agents to fight the coronavirus disease of 2019 (COVID-19), emetine is one of the strongest anti-SARS-CoV-2 compounds with sub-micromolar EC(50) values, identified in several studies and high-throughput screening efforts. The reported...
Autor principal: | Valipour, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159504/ https://www.ncbi.nlm.nih.gov/pubmed/35702393 http://dx.doi.org/10.1021/acsptsci.2c00045 |
Ejemplares similares
-
The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp
por: Gurung, Arun Bahadur, et al.
Publicado: (2021) -
Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors
por: Valipour, Mehdi
Publicado: (2022) -
Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2
por: Bleasel, Martin D., et al.
Publicado: (2020) -
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
por: Choy, Ka-Tim, et al.
Publicado: (2020) -
Emetine
por: Servoss, George L.
Publicado: (1909)